Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Impact of Albumin Dialysis With the Molecular Adsorbents Recirculating System (MARS®) in Severely Decompensated Chronic Liver Disease

NCT00614146 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT00614146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00614146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Impact of Albumin Dialysis With the Molecular Adsorbents Recirculating System (MARS®) in Severely Decompensated Chronic Liver Disease
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2003
Completion date
April 30, 2009
Enrollment
59 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure